Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bevilacqua

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patientsG Gasparini, S B Fox, P Verderio, et al.
Journal of Biological Regulators and Homeostatic Agents|March 16, 2013
Could past Chlamydial vascular infection promote the dissemination of Chlamydia pneumoniae to the brain?M Di Pietro, S Filardo, S Cazzavillan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinomaG Gasparini, N Weidner, P Bevilacqua, et al.
Cell Regulation|May 1, 1991
Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1D B Taichman, M I Cybulsky, I Djaffar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic featuresG Gasparini, W J Gullick, P Bevilacqua, et al.
The Journal of Biological Chemistry|May 27, 1994
Inositol polyanions. Noncarbohydrate inhibitors of L- and P-selectin that block inflammationO Cecconi, R M Nelson, W G Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancerG Gasparini, M Barbareschi, C Doglioni, et al.
International Journal of Cancer|June 21, 1996
Prognostic and predictive value of tumour angiogenesis in ovarian carcinomasG Gasparini, E Bonoldi, G Viale, et al.
The American Journal of Pathology|December 1, 1992
Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissuesJ M Munro, S K Lo, C Corless, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical studyG Gasparini, W J Gullick, S Maluta, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patientsG Gasparini, S B Fox, P Verderio, et al.
Journal of Biological Regulators and Homeostatic Agents|March 16, 2013
Could past Chlamydial vascular infection promote the dissemination of Chlamydia pneumoniae to the brain?M Di Pietro, S Filardo, S Cazzavillan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinomaG Gasparini, N Weidner, P Bevilacqua, et al.
Cell Regulation|May 1, 1991
Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1D B Taichman, M I Cybulsky, I Djaffar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic featuresG Gasparini, W J Gullick, P Bevilacqua, et al.
The Journal of Biological Chemistry|May 27, 1994
Inositol polyanions. Noncarbohydrate inhibitors of L- and P-selectin that block inflammationO Cecconi, R M Nelson, W G Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancerG Gasparini, M Barbareschi, C Doglioni, et al.
International Journal of Cancer|June 21, 1996
Prognostic and predictive value of tumour angiogenesis in ovarian carcinomasG Gasparini, E Bonoldi, G Viale, et al.
The American Journal of Pathology|December 1, 1992
Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissuesJ M Munro, S K Lo, C Corless, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical studyG Gasparini, W J Gullick, S Maluta, et al.
Pageof 12